FilingReader Intelligence

Porton Pharma controlling shareholders pledge shares worth 422.8m yuan

July 22, 2025 at 09:22 AM UTC•By FilingReader AI

Chongqing Porton Pharma Solutions' controlling shareholders pledged additional shares and extended existing pledges worth 422.8 million yuan. Zhang Hebing pledged 12 million shares to repay loans, while Tao Rong extended pledges on 26.27 million shares until March 2026.

The controlling shareholders now have 70.08 million pledged shares, representing 48.33% of their total holdings.

Separately, the board appointed Meng Fan as deputy general manager.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

Announcement regarding the pledge, pledge extension, and release of pledge of some shares held by the actual controllerJuly 22, 2025 at 01:06 AM UTC

Supplementary Source Documents

Announcement of resolutions from the second extraordinary meeting of the sixth session of the board of directorsJuly 22, 2025 at 01:06 AM UTC

Announcement regarding the appointment of additional senior management personnelJuly 22, 2025 at 01:06 AM UTC

Porton Pharma Solutions

SZSE:300363•Shenzhen Stock Exchange

RSS feed for Porton Pharma Solutions

News Alerts

Get instant email alerts when Porton Pharma Solutions publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →